Quick Results
Professional Photo
Professionals

Jeffrey I. Davis

Of Counsel/Senior Advisor
Washington, D.C.
T: 202.508.3414
F: 202.508.3402

Jeff Davis helps clients navigate the complex policy and legal issues surrounding the 340B drug pricing program, including Medicare and Medicaid-related compliance requirements, and provides clients with strategic policy advice and counsel on health care matters.

Featured Video

HHS Requests Comments on Proposed 340B Program Changes to Reduce Drug Prices June 13, 2018

Professional Biography

Overview

Mr. Davis provides clients with counsel on issues relating to the federal 340B drug pricing program, including enrollment; contracting; audits; compliance with 340B, Medicare, and Medicaid requirements; and self-disclosures, as well as other health care matters. He also provides advocacy and policy services to health care providers.

Prior to joining the Firm, Mr. Davis served as vice president and legislative and policy counsel for 340B Health, a nonprofit organization of more than 1,300 hospitals and health systems participating in the 340B drug pricing program. During his more than seven years with 340B Health, he provided hospitals with technical assistance on 340B, Medicare, and Medicaid program compliance issues, oversaw research and policy efforts, and helped lead the government relations team in their work to educate members of Congress and their staff on the importance of the 340B program to hospitals and their patients. Mr. Davis is also a frequent speaker at major industry forums, making regular presentations at annual 340B Coalition conferences, state hospital association meetings, drug manufacturer conferences, and other professional association events.

Mr. Davis previously served as the health care legislative assistant for U.S. Representative Shelley Berkley (D-NV), where he advised Rep. Berkley on health care issues and legislation before Congress and the House Ways and Means Committee and partnered with health care providers to promote increased Medicare funding for hospitals, physicians, nursing homes, acute care and long term care facilities, and other providers.

Publications
Speaking Engagements
  • "340B Legislative Update," 340B Coalition Winter Conference (January 2019)
  • "Exploring Changes to Medicare Part B Drug Reimbursement," 340B Coalition Winter Conference (January 2019)
  • "Community Benefit Reporting and Community Health Needs Assessment," 340B Coalition Winter Conference (January 2019)
  • "International Pricing Index Payment Model," 340B Health Webinar (November 2018)
  • "340B Drug Pricing Program: Past, Present and Future," D.C. Bar panel (September 2018)
  • "The Impact of 340B Reimbursement Cuts on Cancer Centers," Association of American Cancer Institutes (AACI) webinar (September 2018)
  • "Update and Submitting Comments on 2019 Proposed OPPS Rule," 340B Health Webinar (August 2018)
  • "340B Legislative Update," 340B Coalition Annual Conference (July 2018)
  • "Medicare Payment Cuts to 340B Hospitals — Financial and Operational Impact," 340B Coalition Annual Conference (July 2018)
  • "Understanding Medicare Provider Based Rules and Implications for 340B Child Site Registration," 340B Coalition Annual Conference (July 2018)
  • "PBM Panel Discussion," American Pharmacy Purchasing Alliance Pharmacon Expo (June 2018)
  • "340B Legislative Update," 340B Coalition Winter Conference (February 2018)
  • "Medicare Payment Cuts to 340B Hospitals: Operationalizing Modifiers and Evaluating Next Steps," 340B Coalition Winter Conference (February 2018)
  • "Navigate the Complexities of 340B and Its Impact on Pricing and Contracting," Reimbursement and Contracting (September 2017)
  • "340B Self-Disclosures," Medicaid Drug Rebate Program Summit (September 2017)
  • "Covered Entity Operational Insights and Case Study Examples," 340B Manufacturer Summit (August 2017)
  • "340B and Specialty Drugs," 340B Coalition Annual Conference (July 2017)
  • "Managing the Implementation and Operational Challenges Resulting from Significant Changes to the 340B Program," 11th "Big Four" Pharmaceutical Pricing Boot Camp (May 2017)
  • "Medicaid Billing and Reimbursement," 340B Coalition Winter Conference (February 2017)
  • "Orphan Drugs, Left Without a Home: The Impact of 340B Exclusions," Iowa Hospital Association Annual Meeting (October 2016)
  • "340B Essentials," Florida Institute of Certified Public Accountants Health Care Industry Conference (April 2016)
Press Releases

Education

  • Boston University School of Law, J.D., 2010
    • Boston University Public Interest Law Journal, managing editor
  • University of Maryland, B.A., 2005, magna cum laude

Admissions

  • District of Columbia, 2018
  • Maryland, 2010

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept